Economic and Clinical Outcomes Assessment of Immuno-Oncology Agents: A Guide for Payer Decision Makers

Reserve your spot today for this Satellite Dinner Symposium!

Jointly provided by
    Impact Education, LLC
This activity is supported by independent educational grants from Bristol-Myers Squibb and Merck & Co., Inc.
Thursday, April 23, 2020
6:00 PM - 8:00 PM
George R. Brown Convention Center
Room: 382
Houston, TX

Please note: Registration for AMCP 2020 is not required to attend this symposium.

Due to the recent outbreak of COVID-19, AMCP has made the decision to cancel their annual meeting in Houston. For more information about this cancellation, please visit AMCP's website: In the meantime, please visit the Impact Education, LLC ® website for more free CE opportunities on current managed care topics.
  Learn About
  • Latest trial results on checkpoint inhibitors and CAR-T therapies
  • MOA of novel immuno-oncology agents
  • Key outcome measures and payment models in immuno-oncology
  Expert Faculty Presenters
Yung Lyou, MD, PhD
Assistant Clinical Professor, Department of Medical Oncology
City of Hope
Edmund Pezalla, MD, MPH
Enlightenment Bioconsult, LLC
  Who Should Attend?

This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of the AMCP, and other managed health care professionals attending the AMCP 2020 Managed Care and Specialty Pharmacy Annual Meeting.

  Statement of Need/Program Overview

The advent and rapid escalation of targeted cancer therapies has led to the emergence of sophisticated immuno-oncology agents. However, the historically high cost of these agents has compelled payers to initiate strategies to control utilization and manage costs. Because of the explosive growth of this category and their corresponding budgetary impact, healthcare decision makers (HCDMs) and managed care professionals require education on the principles of immuno-oncology and the mechanisms of action behind these novel treatments. Furthermore, given increased focus on value-based benefit design, utilization management, and payer-led clinical interventions to address shortfalls in oncology practice, managed care stakeholders also have a need for information to effectively address the evolving paradigm of cancer treatment. This symposium will provide HCDMs and managed care professionals with the required education on the principles of immuno-oncology and the mechanisms of action behind these novel treatments.

  Educational Objectives

At the conclusion of this activity, participants should be able to demonstrate improved ability to:
  • Characterize the role of the immune system in immunosurveillance and elimination of malignant cell lines
  • Explain the mechanisms of action of novel immuno-oncology agents such as PD-1 and PD-L1 inhibitors and CAR-T therapies
  • Describe key outcomes measures in immuno-oncology and the importance of cumulative assessment of outcomes
  • Apply comprehensive analyses of emerging clinical trial data for checkpoint inhibitors and CAR-T therapies
  • Illustrate current and proposed payer initiatives for the funding and management of checkpoint inhibitors and CAR-T therapies

Date and Time
Thursday, April 23, 2020
6:00 PM - 8:00 PM
George R. Brown Convention Center
Room: 382
Houston, TX

6:00 PM Pre-Activity Learning Assessment and Opening Comments/Overview
Edmund Pezalla, MD, MPH
6:05 PM Clinical Update on the Evolving Immuno-Oncology Treatment Paradigm
Yung Lyou, MD, PhD
6:50 PM Evidence-based Decision Making in a Cost Conscience Environment
Edmund Pezalla, MD, MPH
7:15 PM Medical and Pharmacy Management Strategies to Enhance Outcomes Requiring Treatment with Immuno-Oncology Agents
Edmund Pezalla, MD, MPH
7:40 PM Audience Q&A Session
7:55 PM Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation
8:00 PM Adjournment
  Accreditation Information
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hours (0.20 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: JA4008162-9999-20-1075-L01-P
Type of Activity: Application

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Americans with Disabilities Act
♿ Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.

Fee Information
No additional fee is required to attend this CME/CPE activity.

Please note: No additional fee is required to attend this CME/CPE activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2020 is required.

Pre-registration will close at 12:00 pm on April 22, 2020.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email